Malcolm G. Witter - 30 Aug 2022 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Erika L. Eves for Malcolm G. Witter, by power of attorney
Issuer symbol
N/A
Transactions as of
30 Aug 2022
Net transactions value
$0
Form type
4
Filing time
01 Sep 2022, 21:46:43 UTC
Previous filing
01 Aug 2022
Next filing
04 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +2,500 +1.6% $0.000000 158,888 31 Aug 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAVB Series I Convertible Preferred Stock Purchase +115 115 30 Aug 2022 Common Stock 255,530 $0.4500 Direct F3, F4
transaction NAVB Warrant to Purchase Common Stock Purchase +115 115 30 Aug 2022 Common Stock 255,530 $0.5000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
F2 Issuance deferred at the request of the Reporting Person.
F3 The Reporting Person acquired the Series I Convertible Preferred Stock and Warrants to Purchase Common Stock pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering ("Rights Offering"), as disclosed in the Registration Statement on Form S-1, as amended, and Prospectus Supplement No. 1 filed by the Issuer with the Securities and Exchange Commission. Pursuant to the Rights Offering, the Reporting Person purchased units at a subscription price of $1,000 per unit, with each unit consisting of one (1) share of Series I Convertible Preferred Stock and one (1) Warrant to Purchase 2,222 shares of Common Stock.
F4 Series I Convertible Preferred Stock, par value $.001 per share, is convertible at any time and has no expiration date.